Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:
Aeva Technologies, Inc. (AEVA - Free Report) is building the next-generation of sensing and perception for autonomous vehicles and beyond. The Zacks Consensus Estimate for its current year earnings has been revised 2.8% downward over the last 30 days.
Baidu, Inc. (BIDU - Free Report) provides internet search services. The Zacks Consensus Estimate for its current year earnings has been revised 4.2% downward over the last 30 days.
CymaBay Therapeutics, Inc. is a biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 0.9% downward over the last 30 days.
Dicerna Pharmaceuticals, Inc. is focused on the discovery and development of innovative treatments for rare inherited diseases involving the liver and for cancers. The Zacks Consensus Estimate for its current year earnings has been revised 5.7% downward over the last 30 days.
Ferrari N.V. (RACE - Free Report) is engaged in designing, manufacturing and selling sports cars. The Zacks Consensus Estimate for its current year earnings has been revised 4.3% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Free Report – The Bitcoin Profit Phenomenon
Zacks Investment Research has released a Special Report to help you pursue massive profits from the world’s first and largest decentralized form of money.
No guarantees for the future, but in the past three presidential election years, Bitcoin’s returns were as follows: 2012 +272.4%, 2016 +161.1%, and 2020 +302.8%.
Zacks predicts another significant surge. Click below for Bitcoin: A Tumultuous Yet Resilient History.
Download Now – Today It’s FREE >>
Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:
Aeva Technologies, Inc. (AEVA - Free Report) is building the next-generation of sensing and perception for autonomous vehicles and beyond. The Zacks Consensus Estimate for its current year earnings has been revised 2.8% downward over the last 30 days.
Baidu, Inc. (BIDU - Free Report) provides internet search services. The Zacks Consensus Estimate for its current year earnings has been revised 4.2% downward over the last 30 days.
CymaBay Therapeutics, Inc. is a biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 0.9% downward over the last 30 days.
Dicerna Pharmaceuticals, Inc. is focused on the discovery and development of innovative treatments for rare inherited diseases involving the liver and for cancers. The Zacks Consensus Estimate for its current year earnings has been revised 5.7% downward over the last 30 days.
Ferrari N.V. (RACE - Free Report) is engaged in designing, manufacturing and selling sports cars. The Zacks Consensus Estimate for its current year earnings has been revised 4.3% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Free Report – The Bitcoin Profit Phenomenon
Zacks Investment Research has released a Special Report to help you pursue massive profits from the world’s first and largest decentralized form of money.
No guarantees for the future, but in the past three presidential election years, Bitcoin’s returns were as follows: 2012 +272.4%, 2016 +161.1%, and 2020 +302.8%.
Zacks predicts another significant surge. Click below for Bitcoin: A Tumultuous Yet Resilient History.
Download Now – Today It’s FREE >>
Get the latest research report on BIDU - FREE
Get the latest research report on RACE - FREE
Get the latest research report on AEVA - FREE